Dr. Reddy's Laboratories Ltd, CTO Unit 1

Form 483 issued May 5, 2023 · Sangareddy, India

Inspection
May 1 – May 5, 2023
Observations
1
Pages
1
FEI number
3002806851

In short: On May 5, 2023, FDA issued a Form 483 with 1 observation to Dr. Reddy's Laboratories Ltd, CTO Unit 1 in Sangareddy, Telangana (FEI 3002806851) after an inspection that ran May 1 – May 5, 2023. The investigator was Patty P. Kaewussdangkul. Most observations concern materials; the most-cited regulation is 21 CFR 211.80 (general requirements).

At a glance

1 of 1 observations on this 483 concern materials.

Materials1

Most cited: 21 CFR 211.80 (1×)

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    Components were not tested to ensure that storage conditions are appropriate to…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Dr. Reddy's Laboratories Ltd, CTO Unit 1?

FDA listed 1 observation on this Form 483, mostly about materials. The most-cited regulation is 21 CFR 211.80 (general requirements). The opening words of each observation are shown on this page.

Who inspected Dr. Reddy's Laboratories Ltd, CTO Unit 1?

Patty P. Kaewussdangkul is named on this Form 483, for the inspection of May 1 – May 5, 2023. Each investigator has a profile showing what they cite most.

When was Dr. Reddy's Laboratories Ltd, CTO Unit 1 inspected by FDA?

The inspection ran May 1 – May 5, 2023, and the Form 483 is dated May 5, 2023.

How do I get the full Form 483 for Dr. Reddy's Laboratories Ltd, CTO Unit 1?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free